These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33536242)

  • 1. BLISS in the Treatment of Lupus Nephritis.
    Thurman JM
    Clin J Am Soc Nephrol; 2021 Jun; 16(6):969-971. PubMed ID: 33536242
    [No Abstract]   [Full Text] [Related]  

  • 2. Belimumab (Benlysta) for lupus nephritis.
    Med Lett Drugs Ther; 2021 Sep; 63(1634):e3-e4. PubMed ID: 34606490
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab-refractory lupus nephritis successfully treated with belimumab.
    Gonzalez-Echavarri C; Ugarte A; Ruiz-Irastorza G
    Clin Exp Rheumatol; 2016; 34(2):355-6. PubMed ID: 26886714
    [No Abstract]   [Full Text] [Related]  

  • 4. Eculizumab as rescue therapy in severe resistant lupus nephritis.
    Pickering MC; Ismajli M; Condon MB; McKenna N; Hall AE; Lightstone L; Terence Cook H; Cairns TD
    Rheumatology (Oxford); 2015 Dec; 54(12):2286-8. PubMed ID: 26316577
    [No Abstract]   [Full Text] [Related]  

  • 5. BLISS-LN trial revisited: function matters.
    Gleeson S; Lightstone L
    Kidney Int; 2022 Feb; 101(2):224-226. PubMed ID: 35065691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
    Fließer EE; Korsten P; Koziolek MJ; Niewold TB; Patschan D; Müller GA; Patschan SA
    Lupus; 2013 Dec; 22(14):1523-5. PubMed ID: 24014569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
    Furie R; Toder K; Zapantis E
    Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belimumab in Lupus Nephritis.
    Schönermarck U; Kemmner S; Fischereder M
    N Engl J Med; 2021 Jan; 384(2):187-188. PubMed ID: 33497558
    [No Abstract]   [Full Text] [Related]  

  • 9. Belimumab in Lupus Nephritis.
    Rojas-Rivera J; Ortiz A; Carriazo S
    N Engl J Med; 2021 Jan; 384(2):187. PubMed ID: 33497557
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombotic microangiopathy with refractory lupus nephritis successfully treated by combining rituximab with belimumab.
    Hanai S; Kobayashi Y; Ito R; Harama K; Nakagomi D
    Scand J Rheumatol; 2023 Mar; 52(2):227-229. PubMed ID: 36409225
    [No Abstract]   [Full Text] [Related]  

  • 11. Belimumab in Lupus Nephritis. Reply.
    Furie R; Rovin BH; Roth DA
    N Engl J Med; 2021 Jan; 384(2):188. PubMed ID: 33497559
    [No Abstract]   [Full Text] [Related]  

  • 12. [Belimumab as add-on treatment in lupus nephritis (summary of the BLISS-LN trial)].
    Hadjiski D
    Z Rheumatol; 2021 Apr; 80(3):283-284. PubMed ID: 33512537
    [No Abstract]   [Full Text] [Related]  

  • 13. Lupus nephritis: the evolving role of novel therapeutics.
    Rovin BH; Parikh SV
    Am J Kidney Dis; 2014 Apr; 63(4):677-90. PubMed ID: 24411715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
    Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?
    Parodis I; Houssiau FA
    Ann Rheum Dis; 2022 Jan; 81(1):15-19. PubMed ID: 34521616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why will lupus nephritis trials not fail anymore?
    Houssiau FA
    Rheumatology (Oxford); 2017 May; 56(5):677-678. PubMed ID: 27338083
    [No Abstract]   [Full Text] [Related]  

  • 17. Belimumab for the treatment of systemic lupus erythematosus.
    Jordan N; D'Cruz DP
    Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics.
    Oliva-Damaso N; Bomback AS
    Am J Kidney Dis; 2021 Jun; 77(6):984-987. PubMed ID: 33221369
    [No Abstract]   [Full Text] [Related]  

  • 19. Rethinking biologics in lupus nephritis.
    Venuturupalli S
    Lupus; 2016 Sep; 25(10):1102-10. PubMed ID: 27497255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
    Furie R; Rovin BH; Houssiau F; Malvar A; Teng YKO; Contreras G; Amoura Z; Yu X; Mok CC; Santiago MB; Saxena A; Green Y; Ji B; Kleoudis C; Burriss SW; Barnett C; Roth DA
    N Engl J Med; 2020 Sep; 383(12):1117-1128. PubMed ID: 32937045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.